WATSON 605 (Labetalol 100 mg)
Pill imprint WATSON 605 has been identified as Labetalol hydrochloride 100 mg.
Labetalol is used in the treatment of hypertensive emergency; high blood pressure; pheochromocytoma; postural orthostatic tachycardia syndrome; mitral valve prolapse and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Labetalol 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 605
- Strength:
- 100 mg
- Color:
- Beige
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Non-cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-0605
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
corn starch
water
titanium dioxide
ferric oxide red
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-5928 | Major Pharmaceuticals |
| 21695-0592 | Rebel Distributors Corp (repackager) |
| 60429-0277 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about labetalol
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
